Amy Bobbins, MPharm, MSc

Research Fellow
Drug Safety Research Unit, United Kingdom

Poster(s):

• (037) The public health impact of suspending cyproterone acetate (2mg)/ethinylestradiol (35µg) in France: A predictive modelling technique to estimate adverse drug reactions prevented by regulatory action
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST